Tarlatamab is a bispecific T-cell engager (BiTE) that binds to delta-like ligand-3 (DLL3) on small cell lung cancer (SCLC) cells and cluster of differentiation-3 on T cells, thereby delivering ...
In a recent study posted to the medRxiv* preprint server, researchers immunophenotyped T lymphocyte responses among unvaccinated individuals, representative of the entire spectrum of the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback